{
  "metformin": {
    "molecule": "Metformin",
    "trials": [
      {
        "trial_id": "NCT00011111",
        "title": "Metformin for treatment of NAFLD in adults",
        "phase": "Phase 2",
        "status": "Recruiting",
        "condition": "Non-alcoholic fatty liver disease",
        "sponsor": "Academic Hospital A",
        "start_date": "2023-01-15",
        "estimated_completion_date": "2026-06-30",
        "registry": "ClinicalTrials.gov",
        "locations": ["US", "Canada"],
        "repurposing_flag": true
      },
      {
        "trial_id": "NCT00022222",
        "title": "Metformin add-on therapy in insulin-resistant obesity",
        "phase": "Phase 3",
        "status": "Active, not recruiting",
        "condition": "Obesity with insulin resistance",
        "sponsor": "BigPharma Inc.",
        "start_date": "2021-05-01",
        "estimated_completion_date": "2025-12-31",
        "registry": "ClinicalTrials.gov",
        "locations": ["EU", "US"],
        "repurposing_flag": false
      },
      {
        "trial_id": "NCT00033333",
        "title": "Low-dose metformin in prediabetes",
        "phase": "Phase 4",
        "status": "Completed",
        "condition": "Prediabetes",
        "sponsor": "University B",
        "start_date": "2018-03-10",
        "estimated_completion_date": "2022-07-15",
        "registry": "WHO ICTRP",
        "locations": ["India"],
        "repurposing_flag": false
      }
    ]
  },

  "montelukast": {
    "molecule": "Montelukast",
    "trials": [
      {
        "trial_id": "NCT11112222",
        "title": "Montelukast for chronic urticaria",
        "phase": "Phase 2",
        "status": "Recruiting",
        "condition": "Chronic spontaneous urticaria",
        "sponsor": "Dermato Pharma",
        "start_date": "2022-09-01",
        "estimated_completion_date": "2025-01-31",
        "registry": "ClinicalTrials.gov",
        "locations": ["Germany"],
        "repurposing_flag": true
      }
    ]
  }
}
